DekaBank Deutsche Girozentrale
ARNA

DekaBank Deutsche Girozentrale’s Arena Pharmaceuticals Inc ARNA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,950
Closed -$1.59M – 1517
2021
Q3 		$1.59M Hold
26,950
– – ﹤0.01% 781
2021
Q2 		$1.87M Hold
26,950
– – 0.01% 744
2021
Q1 		$1.8M Hold
26,950
– – 0.01% 729
2020
Q4 		$2.09M Sell
26,950
-3,350
-11% -$251K 0.01% 658
2020
Q3 		$2.27M Buy
+30,300
New +$2.02M 0.01% 571
2019
Q3 		– Sell
-66,400
Closed -$3.85M – 1160
2019
Q2 		$3.85M Buy
66,400
+25,800
+64% +$1.33M 0.02% 474
2019
Q1 		$1.58M Buy
40,600
+7,400
+22% +$339K 0.01% 660
2018
Q4 		$1.28M Sell
33,200
-7,400
-18% -$291K 0.01% 624
2018
Q3 		$1.58M Sell
40,600
-1,100
-3% -$44.6K 0.01% 672
2018
Q2 		$1.76M Buy
41,700
+25,000
+150% +$1.07M 0.01% 613
2018
Q1 		$661K Buy
+16,700
New +$650K ﹤0.01% 816
2016
Q2 		– Sell
-10,100
Closed -$193K – 1067
2016
Q1 		$193K Sell
10,100
-2,200
-18% -$35.3K ﹤0.01% 853
2015
Q4 		$239K Buy
12,300
+100
+0.8% +$2.04K ﹤0.01% 833
2015
Q3 		$233K Buy
12,200
+450
+4% +$15.3K ﹤0.01% 835
2015
Q2 		$545K Buy
11,750
+450
+4% +$19.5K 0.01% 686
2015
Q1 		$494K Sell
11,300
-500
-4% -$23.2K 0.01% 718
2014
Q4 		$401K Sell
11,800
-1,050
-8% -$42.6K 0.01% 740
2014
Q3 		$538K Buy
12,850
+250
+2% +$11.2K 0.01% 638
2014
Q2 		$738K Sell
12,600
-550
-4% -$34.6K 0.01% 541
2014
Q1 		$828K Buy
13,150
+700
+6% +$46.4K 0.01% 502
2013
Q4 		$732K Buy
12,450
+300
+2% +$15.7K 0.01% 493
2013
Q3 		$640K Buy
+12,150
New +$816K 0.01% 516

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ARNA Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 26,950 shares — an estimated $1.59M sold.

DekaBank Deutsche Girozentrale first reported a position in ARNA in Q3 2013 and held it in 22 quarters. The position peaked at $3.85M in Q2 2019. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 26,950 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $1.59M.
  • DekaBank Deutsche Girozentrale first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 22 quarters.
  • DekaBank Deutsche Girozentrale's Arena Pharmaceuticals Inc position peaked at $3.85M in Q2 2019.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.